Event coordinated by the Hepatitis B Foundation

2026 International HBV Meeting

This conference is being held from 6–10 September in Singapore, bringing together the HBV community for a focused exchange of the latest unpublished research and emerging data.

The meeting is structured around three core themes:

 
  • Molecular Virology & HBV/HDV Biology
 
  • Immunology, Pathogenesis & Cellular Interactions
 
  • Clinical Science & Therapeutic Approaches

Across these areas, the program will feature:

 
  • In-depth exploration of HBV and HDV molecular virology 
 
  • Integrated sessions bridging clinical, virological, and immunological research 
 
  • New data from therapeutic development and cure-focused strategies 
 
  • Advances in experimental models and technologies
 
  • Grand Discussion panels with key opinion leaders
 
  • Joint sessions with the affected community, clinicians, and scientists, highlighting community-informed perspectives 
 
  • A dedicated trainee workshop for graduate students and postdoctoral fellows 
 
  • Ample opportunities for discussion and networking across career stages

  

Registration is now open.

Make it a full week of HBV science in Singapore. Attendees of the 2026 International HBV Meeting enjoy an exclusive 50% discount for The Science of HBV Cure 2026 (4–5 September, Singapore)—a back-to-back deep dive from fundamental virology to clinical advances. Learn more here.

 

 

Co-Organizers

Nina headshot2

Nina Le Bert, PhD
Assistant Professor, Signature Research Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore

Thomas headshot

Thomas Tu, PhD
Group Leader, Viral Hepatitis Pathogenesis, Storr Liver Centre, Westmead Institute for Medical Research, Australia

2026 Keynote Speakers

Beatty Professional 24

Julia Beatty, PhD
Chair Professor, Veterinary Medicine and Infectious Diseases, Jockey Club College of Veterinary Medicine and Life Sciences [biography]

AG PIC

Arash Grakoui, PhD
Professor of Medicine, Division of Infectious Diseases at the Emory University School of Medicine and Professor of Microbiology and Immunology, Emory University [biography]

 

2026 Distinguished Award in Hepatitis B Research recipient
20220513 tavis 003
John Tavis, PhD
Professor, Saint Louis University Director, Institute for Drug and Biotherapeutic Innovation [biography and past awardees]